Does the dexamethasone dose correlate with the QoR score?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034585

Enrollment

500

Registered

2024-07-12

Start date

2022-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degree of recovery and impact on PONV after surgery.

Interventions

Group 1: All patients who are getting surgery at University Hospital of Saarland from 01.08.2022 to 31.12.2023 in otorhinolaryngology, urology, gynecology, orthopedics, trauma surgery, general surgery

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: planned inpatient surgery unrestricted knowledge of German

Exclusion criteria

Exclusion criteria: an outpatient or emergency operation cardiothoracic surgery

Design outcomes

Primary

Measure	Time frame
The QoR-15 score is linearly higher in patients with a higher dose of dexamethasone/kg bodyweight than in patients with a lower dose of dexamethasone/kg bodyweight.	—

Secondary

Measure	Time frame
PONV (QoR question 0-10 points) is linearly less pronounced in patients with a higher dose of dexamethasone/kg body weight than in patients with a lower dose of dexamethasone/kg body weight.	—

Countries

Germany

Contacts

Public ContactThomas Volk

Universitätsklinikum des Saarlandes, Lehrstuhl Anästhesiologie

claudia.roehn@uks.eu+496841 – 1622485

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026